CXCL8 and COVID-19: Using >300 pg/ml as the cut-off for IL6 and >200 pg/ml IL8 in our study, 50% of the patients with progressive (moderate or severe) COVID-19 can be identified for early therapeutic intervention (Fig. 6G and Supplementary Table S2).